Ausgabe 1/2018
Inhalt (17 Artikel)
CircRNA: a novel type of biomarker for cancer
He-da Zhang, Lin-hong Jiang, Da-wei Sun, Jun-chen Hou, Zhen-ling Ji
Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis
Zhu Yu, Xiaojing Guo, Yicheng Jiang, Lei Teng, Jinwu Luo, Pengfei Wang, Yunsheng Liang, Haitian Zhang
Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
Loay Kassem, Kyrillus S. Shohdy, Shaimaa Lasheen, Omar Abdel-Rahman, Thomas Bachelot
Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature
Daniela Treitl, Pejman Radkani, Magda Rizer, Siba El Hussein, Juan C. Paramo, Thomas W. Mesko
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
Nobumoto Tomioka, Manabu Azuma, Mayuko Ikarashi, Mitsugu Yamamoto, Masako Sato, Ken-ichi Watanabe, Katsushige Yamashiro, Masato Takahashi
Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy
Naoko Matsuda, Kumiko Kida, Sachiko Ohde, Koyu Suzuki, Hideko Yamauchi, Seigo Nakamura, Hiroko Tsunoda
Effect of allyl isothiocyanate on NF-κB signaling in 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea-induced mammary carcinogenesis
Thangarasu Rajakumar, Pachaiappan Pugalendhi, Rajendran Jayaganesh, Dhanabalan Ananthakrishnan, Krishnaswamy Gunasekaran
Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan
Yuri Mizota, Yasuo Ohashi, Takuji Iwase, Hiroji Iwata, Masataka Sawaki, Takayuki Kinoshita, Naruto Taira, Hirofumi Mukai, Seiichiro Yamamoto
Individual difference in pectoralis major muscle thickness and its effect on single-stage breast reconstruction using a tissue expander
Naohiro Ishii, Jiro Ando, Michiko Harao, Masaru Takemae, Kazuo Kishi
The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells
Katsuya Nakai, Weiya Xia, Hsin-Wei Liao, Mitsue Saito, Mien-Chie Hung, Hirohito Yamaguchi
Objective assessment of reconstructed breast hardness using a durometer
Hiroki Mori, Noriko Uemura, Haruka Koga, Mutsumi Okazaki
Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer
Rikiya Nakamura, Naohito Yamamoto, Toshiko Miyaki, Makiko Itami, Nobumitsu Shina, Masayuki Ohtsuka
Management of contralateral breast following mastectomy and breast reconstruction using a mirror adjustment with crescent mastopexy technique
A. Cogliandro, B. Brunetti, Mauro Barone, G. Favia, P. Persichetti
Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone
Jiqiao Yang, Shenli Tang, Yuting Zhou, Juanjuan Qiu, Juying Zhang, Sui Zhu, Qing Lv
Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
Masaya Hattori, Hiroshi Ishiguro, Norikazu Masuda, Akiyo Yoshimura, Shoichiro Ohtani, Hiroyuki Yasojima, Satoshi Morita, Shinji Ohno, Hiroji Iwata
Inter-observer agreement among pathologists in grading the pathological response to neoadjuvant chemotherapy in breast cancer
Takeshi Yamaguchi, Hirofumi Mukai, Futoshi Akiyama, Koji Arihiro, Shinobu Masuda, Masafumi Kurosumi, Yoshinori Kodama, Rie Horii, Hitoshi Tsuda
Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
Masaya Hattori, Hiroshi Ishiguro, Norikazu Masuda, Akiyo Yoshimura, Shoichiro Ohtani, Hiroyuki Yasojima, Satoshi Morita, Shinji Ohno, Hiroji Iwata